HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma.

AuthorsL Cany, O Fitoussi, J M Boiron, G Marit
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 20 Issue 8 Pg. 2212 (Apr 15 2002) ISSN: 0732-183X [Print] United States
PMID11956286 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Thalidomide
Topics
  • Antineoplastic Agents (adverse effects)
  • Female
  • Humans
  • Middle Aged
  • Multiple Myeloma (drug therapy)
  • Thalidomide (adverse effects)
  • Tumor Lysis Syndrome (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: